Discoidin domain receptor inhibitors as anticancer agents: A systematic review on recent development of DDRs inhibitors, their resistance and structure activity relationship
Article in Bioorganic Chemistry (October 2022)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
YES1: A Novel Therapeutic Target and Biomarker in Cancer.
Article in Molecular Cancer Therapeutics (June 2022)
DDR1 and DDR2: a review on signaling pathway and small molecule inhibitors as an anticancer agent
Article in Medicinal Chemistry Research (January 2021)